# Feasibility Study of Multi-Platform Profiling of Resected Biliary Tract Cancer

> **NCT04561453** · — · TERMINATED · sponsor: **University of Washington** · enrollment: 14 (actual)

## Conditions studied

- Biliary Tract Cancer
- Cholangiocarcinoma
- Gallbladder Cancer
- Intrahepatic Cholangiocarcinoma
- Perihilar Cholangiocarcinoma
- Extrahepatic Cholangiocarcinoma
- Hilar Cholangiocarcinoma
- Distal Bile Duct Cancer

## Interventions

- **DIAGNOSTIC_TEST:** Multi-Platform Profiling with Organoid Drug Sensitivity Screening and ctDNA Monitoring

## Key facts

- **NCT ID:** NCT04561453
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2020-07-08
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-04-04
- **Target enrollment:** 14 (ACTUAL)
- **Why stopped:** Study terminated due to end of funding
- **Last updated:** 2025-07-10

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04561453

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04561453, "Feasibility Study of Multi-Platform Profiling of Resected Biliary Tract Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04561453. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*